Benzinga | Oct 28, 2021 04:45PM EDT

Bio-Rad Laboratories Q3 EPS $3.71 Beats $2.44 Estimate, Sales $747.00M Beat $661.87M Estimate

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $3.71 per share which beat the analyst consensus estimate of $2.44 by 52.05 percent. This is a 23.67 percent increase over earnings of $3.00 per share from the same period last year. The company reported quarterly sales of $747.00 million which beat the analyst consensus estimate of $661.87 million by 12.86 percent. This is a 15.41 percent increase over sales of $647.26 million the same period last year.